• Home
• Partneringtools
• Reports

• In-licensing
• Out-licensing
• Companies

• Articles
• Events
• Outsourcing

• Consulting
• Jobs
• Forums

• About us
• Products
• Newsletter

Pharmalicensing Ltd
is a division of

— LEEDS, England, April 4

LEEDS, England, April 4 /PRNewswire/ -- Teva UK Limited, the biggest generic drug manufacturer(x) in the UK, has welcomed news that this week's Department of Health's Pharmacy White Paper(^) has opened the way for an expanded role for England's pharmacies.

The paper envisages a number of changes for pharmacy, and the company says that it is pleased that health ministers have recognised the potential for community pharmacy to do more to address access to health and wellbeing services. "Medicines Use Reviews have already shown that community pharmacy, with the support of industry partners, can make a real difference to patients' lives," said Teva's Managing Director John Beighton. "They also show that pharmacy has the capability and resolve to do more under the Contract. The White Paper can move this forward and position pharmacy as an essential component of delivering healthcare in the community."

Mr Beighton called on contractors to make the most of the sources of help they already have to be in the best position to capitalise on new opportunities. "Firms like Teva are already offering help to deliver MURs and other services. My message is to say that people like us are available to help - take that help from partners, build relationships with industry that enable contractors to be ready for the first day of every new service."

Mr Beighton added that the company's Partners in Progress programme, launched in late 2007 to help contractors deliver MURs, was an example of how pharmacy and industry partners could work together to provide a sustainable programme that delivers patient care and benefits to pharmacy.

Notes to editors:

(x) - IMS data

(^) - Pharmacy in England: building on strengths - delivering the future published by The Stationery Office on 3 April 2008: http://www.official-documents.gov.uk/document/cm73/7341/7341.pdf

Teva UK Limited is one of the UK's leading pharmaceutical manufacturers, with a presence in the generics, branded respiratory and hospitals markets. Measured by the volume of boxes supplied, it is the biggest single medicines supplier to the NHS. With over 500 product lines, it has the widest range of any UK generic pharmaceutical company and has a number of innovative respiratory products including the Qvar(R) (beclometasone dipropionate) CFC-free inhaler.

Industry news: Pharmalicensing provides comprehensive industry coverage.

Products:	Partnering Consulting	Partnering Search	Company Profiling	Comparision	Partneringtools	Reports
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Outsourcing
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search	Add your event
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic	Post your article
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Company releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us